Rigetti Computing vs. IonQ: Which Quantum Computing Stock Has Better Revenue Momentum?

IonQ is presented as the better quantum computing buy versus Rigetti, with analysts expecting revenue to rise nearly fivefold from $130 million in 2025 to $638 million in 2028, compared with Rigetti's increase from $7 million to $100 million. The article highlights IonQ's stronger government-contract momentum, room-temperature trapped-ion technology, and higher revenues, while noting both companies remain unprofitable and expensive at 32x and 28x 2028 sales, respectively. Overall, the piece is a bullish comparative thesis on IonQ, but it is still framed as speculative and unlikely to materially change the sector outlook.

Analysis

The market is still pricing quantum as a straight-line TAM story, but the first-order winner is likely not the company with the more elegant physics; it is the one that converts experimental credibility into repeatable contract revenue. IonQ’s government/federal mix matters because it shortens the feedback loop between technical progress and cash generation, while also giving it a built-in funding source for system iteration. Rigetti’s smaller base means the same absolute contract wins can look explosive in growth terms, but that also leaves it more vulnerable to any single program delay or a shift in procurement cadence.

A second-order effect is that both names are increasingly competing for the same scarce resource: investor patience. At these valuations, the key variable is not whether quantum computing works in the abstract, but whether either company can create a visible sequence of de-risking milestones over the next 6-12 months — system launches, lease placements, backlog conversion, and evidence of usage intensity. If those indicators stall, multiple compression can outrun revenue growth even if the underlying technology narrative remains intact.

The contrarian read is that the “IonQ is better” conclusion may be too clean. IonQ’s higher quality profile is already reflected in a premium multiple, and the spread versus Rigetti may narrow if Rigetti’s modular roadmap produces more tangible near-term commercialization than expected. Conversely, if government spend proves lumpy or subject to budget timing, IonQ’s revenue mix can amplify volatility rather than reduce it.

Net: this is not a fundamentals-long-only setup; it is a relative-value and catalyst-trading market. The best expression is to own the clearer execution path while fading the lower-confidence monetization story, but only with tight time stops because both names can re-rate violently on single headlines.

Key Decisions for Investors

• Go long IONQ / short RGTI as a 3-6 month pair trade; thesis is quality-of-revenue premium persists, with the spread likely widening if federal contract wins continue to convert into backlog. Size modestly because both are high-beta and can gap on product announcements.
• Use RGTI only as a catalyst trade, not a core long: consider small long exposure ahead of major system launch milestones, but cut quickly if customer adoption metrics do not follow within 1-2 quarters. Risk/reward is asymmetric but execution-dependent.
• For investors seeking pure optionality, buy IONQ call spreads 6-9 months out rather than stock; this captures upside from de-risking events while limiting damage if the market reprices long-duration growth lower.
• Avoid unhedged long exposure in both names until there is evidence of sustained revenue conversion; at current multiples, any delay in commercialization can drive 20-30% drawdowns faster than fundamentals can recover.
• Set a trigger to reassess the pair if either company reports a step-change in contract backlog or system utilization over the next two earnings cycles; that would justify abandoning the valuation anchor and chasing the stronger execution path.